PAPER

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

A Riazi¹, J C Hobart^1,2, D L Lamping³, R Fitzpatrick⁴ and A J Thompson¹

¹ Neurological Outcome Measures Unit, Institute of Neurology, London, UK
² Department of Clinical Neurosciences, Derriford Hospital, Devon, UK
³ Health Services Research Unit, London School of Hygiene and Tropical Medicine, UK
⁴ Department of Public Health and Primary Care, University of Oxford, UK

Correspondence to:
Correspondence to:
Dr J Hobart, Department of Clinical Neurosciences, Derriford Hospital, Plymouth, Devon PL8 8DH, UK;
Jeremy.Hobart{at}phnt.swest.nhs.uk

Background and aim: The psychometric properties of rating scales are sample dependent and need evaluations in different samples. The Multiple Sclerosis Impact Scale (MSIS-29), a new patient based rating scale for multiple sclerosis (MS) was predominantly developed from a community based sample derived from the MS Society. A number of important patient characteristics of this sample remain unknown. The aim of the study was to evaluate five psychometric properties of the MSIS-29 in three hospital based samples: people admitted for rehabilitation, people admitted for intravenous corticosteroid treatment for MS relapses, and people with primary progressive MS.

Methods: People with MS were recruited from the three clinical settings. They completed several health measures. MSIS-29 data were evaluated for data quality, scaling assumptions, acceptability, reliability and validity, and compared with those from a previously reported community based study.

Results: A total of 233 people (rehabilitation =53; corticosteroids =76; primary progressive =104) completed questionnaires. In all samples, missing data were low (2.2%), scaling assumptions were satisfied, and reliability was high (0.91). Correlations between the MSIS-29 and other scales were consistent with a priori hypotheses. Findings were consistent with those from the community samples.

Conclusions: The psychometric properties of the MSIS-29 are consistent across three hospital based samples, and similar to those in the community samples. These findings further support its use as an outcome measure in different clinical settings.

Keywords: multiple sclerosis; Multiple Sclerosis Impact Scale (MSIS-29); health outcomes measurement; psychometric methods

Abbreviations: MS, multiple sclerosis; MSIS-29, Multiple Sclerosis Impact Scale

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hutchinson, M (2009). Predicting and preventing the future: actively managing multiple sclerosis. PN 9: 133-143 [Abstract] [Full Text]  
• Costelloe, L., O'Rourke, K., Kearney, H., McGuigan, C., Gribbin, L., Duggan, M., Daly, L., Tubridy, N., Hutchinson, M. (2007). The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). J. Neurol. Neurosurg. Psychiatry 78: 841-844 [Abstract] [Full Text]  
• van der Linden, F A H, Kragt, J J, Hobart, J C, Klein, M, Thompson, A J, van der Ploeg, H M, Polman, C H, Uitdehaag, B M J (2006). Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life. J. Neurol. Neurosurg. Psychiatry 77: 1157-1162 [Abstract] [Full Text]  
• van der Linden, F A H, Kragt, J J, Klein, M, van der Ploeg, H M, Polman, C H, Uitdehaag, B M J (2005). Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J. Neurol. Neurosurg. Psychiatry 76: 1677-1681 [Abstract] [Full Text]  
• Hobart, J C, Riazi, A, Lamping, D L, Fitzpatrick, R, Thompson, A J (2005). How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J. Neurol. Neurosurg. Psychiatry 76: 1539-1543 [Abstract] [Full Text]  
• Diamond, A, Jankovic, J (2005). The effect of deep brain stimulation on quality of life in movement disorders. J. Neurol. Neurosurg. Psychiatry 76: 1188-1193 [Abstract] [Full Text]  
• Heffernan, C., Jenkinson, C. (2005). Review Paper: Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions. Chronic Illness 1: 131-142 [Abstract]  
• Gruenewald, D A, Higginson, I J, Vivat, B, Edmonds, P, Burman, R E (2004). Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review. Mult Scler 10: 690-725 [Abstract]  
• Cano, S. J., Warner, T. T., Linacre, J. M., Bhatia, K. P., Thompson, A. J., Fitzpatrick, R., Hobart, J. C. (2004). Capturing the true burden of dystonia on patients: The Cervical Dystonia Impact Profile (CDIP-58). Neurology 63: 1629-1633 [Abstract] [Full Text]  
• Hoogervorst, E L., Zwemmer, J N., Jelles, B, Polman, C H, Uitdehaag, B M. (2004). Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler 10: 569-574 [Abstract]  
• McGuigan, C., Hutchinson, M. (2004). Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12). Neurology 62: 2103-2105 [Abstract] [Full Text]  
• Beaumont, J G (2004). The MS symptom and impact diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 75: 526-527 [Full Text]  
• Greenhalgh, J, Ford, H, Long, A F, Hurst, K (2004). The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 75: 577-582 [Abstract] [Full Text]  
• McGuigan, C, Hutchinson, M (2004). The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J. Neurol. Neurosurg. Psychiatry 75: 266-269 [Abstract] [Full Text]  
• Riazi, A, Thompson, A J, Hobart, J C (2004). Self-efficacy predicts self-reported health status in multiple sclerosis. Mult Scler 10: 61-66 [Abstract]